2,5-dimethyl Celecoxib

2,5-dimethyl Celecoxib （订货以CAS编码或英文名称为准）

Product Type|Biochemicals|Small Molecule Inhibitors|Prostaglandin Synthases||Research Area|Cancer|Cell Cycle||Research Area|Cancer|Cell Death|Apoptosis||Research Area|Cancer|Multidrug Resistance||Research Area|Immunology & Inflammation|Inflammatory Lipid Mediators|Prostaglandins||Research Area|Lipid Biochemistry|Cyclooxygenase Pathway

创赛科技提供的所有产品仅用于科研等非医疗用途，非药品不可食用，不可用于人体或动物的临床诊断和治疗,我们不为个人提供产品及服务。如您需要产品COA等资料，可至下方“质量控制”中下载

编号：PC54169

分子式：C18H16N3O2F3S

CAS号：457639-26-8

分子量：395.40

储存条件：-20℃

申请试用

货号	品牌	规格	纯度/含量	标准价	优惠价
PC54169-50mg	Medlife	50mg	≥99%	待询	登录后可见
PC54169-100mg	Medlife	100mg	≥99%	待询	登录后可见
PC54169-10mg	Medlife	EA	≥99%	¥1795.00	登录后可见
PC54169-25mg	Medlife	EA	≥99%	¥3495.00	登录后可见
PC54169-5mg	Medlife	EA		¥955.00	登录后可见

中文名称：	2，5-Dimethyl Celecoxib
中文别名：	2,5 - 二甲基-塞来昔布标准品;2,5-二甲基塞来考昔;WITEGANS0332,5 - 二甲基-塞来昔布标准品
英文名称：	2,5-dimethyl Celecoxib
英文别名：	2,5-Dimethyl Celecoxib;2,5-Dimethyl-celecoxib;2,5-Dimethylcelecoxib 4-[5-(2,5-dimethylphenyl)-3-(trifluoromethyl)-1H-pyrazol-1-yl]-benzenesulfonamide;2,5-Dimethyl-celecoxib DMC;Dimethylcelecoxib, 2,5-;4-[5-(2,5-dimethylphenyl)-3-(trifluoromethyl)pyrazol-1-yl]benzenesulfonamide;4-[5-(2,5-dimethylphenyl)-3-(trifluoromethyl)-1H-pyrazol-1-yl]-benzenesulfonamide;4-[5-(2,5-Dimethylphenyl)-3-(trifluoromethyl)-1H-pyrazol-1-yl]benzenesulfonamide
CAS号：	457639-26-8
分子式：	C18H16N3O2F3S
分子量：	395.40
详细描述	Product Type\|Biochemicals\|Small Molecule Inhibitors\|Prostaglandin Synthases\|\|Research Area\|Cancer\|Cell Cycle\|\|Research Area\|Cancer\|Cell Death\|Apoptosis\|\|Research Area\|Cancer\|Multidrug Resistance\|\|Research Area\|Immunology & Inflammation\|Inflammatory Lipid Mediators\|Prostaglandins\|\|Research Area\|Lipid Biochemistry\|Cyclooxygenase Pathway

搜索质检报告(COA)

相关产品

methyl (Z)-3-hydroxy-4-methylpent-2-enoate & methyl 4-methyl-3-oxopentanoate

Calcium (5R)-7-(2-(4-fluorophenyl)-5-isopropyl-3-phenyl- 4-(phenylcarbamoyl)-1H-pyrrol-1-yl)-5-hydroxy-3- methoxyheptanoate

((R)-7-(2-(4-fluorophenyl)-5-isopropyl-3-phenyl-4-(phenylcarbamoyl)-1H-pyrrol-1-yl)-3-hydroxy-5-oxoheptanoate) calcium(II)

tert-butyl (3S,5R)-7-(2-(4-fluorophenyl)-5-isopropyl-3-phenyl-4- (phenylcarbamoyl)-1H-pyrrol-1-yl)-3,5-dihydroxyheptanoate

tert-butyl (3R,5S)-7-(2-(4-fluorophenyl)-5-isopropyl-3-phenyl-4- (phenylcarbamoyl)-1H-pyrrol-1-yl)-3,5-dihydroxyheptanoate

tert-butyl (3R,5R)-7-((3R,5R)-7-(2-(4-fluorophenyl)-5-isopropyl-3-phenyl-4-(phenylcarbamoyl)-1H-pyrrol-1-yl)-3,5-dihydroxyheptanamido)-3,5-dihydroxyheptanoate

(3R,5R)-tert-butyl 7-(2,3-bis(4-fluorophenyl)-5-isopropyl-4- (phenylcarbamoyl)-1H-pyrrol-1-yl)-3,5-dihydroxyheptanoate

((3R,5S)-7-(2-(4-fluorophenyl)-5-isopropyl-3-phenyl-4-(phenyl carbamoyl)-1H-pyrrol-1-yl)-3,5-dihydroxyheptanoate)calcium(II)

7-(2-(4-fluorophenyl)-5-isopropyl-3-phenyl-4-(phenylcarbamoyl)-1H- pyrrol-1-yl)-5-hydroxy-3-oxoheptanoic acid sodium salt

(3R,5R)-tert-butyl3,5-dihydroxy-7-(2-isopropyl-4,5-diphenyl-3- (phenylcarbamoyl)-1H-pyrrol-1-yl)heptanoate